Net profit of Mankind Pharma rose 30.43% to Rs 653.47 crore in the quarter ended September 2024 as against Rs 501.03 crore during the previous quarter ended September 2023. Sales rose 13.60% to Rs 3076.51 crore in the quarter ended September 2024 as against Rs 2708.10 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 3076.51 | 2708.10 | 14 |
OPM % | 27.63 | 25.21 | - |
PBDT | 954.94 | 737.48 | 29 |
PBT | 849.32 | 640.99 | 33 |
NP | 653.47 | 501.03 | 30 |